Federica Piccioni - Concepedia

Author

Federica Piccioni

Broad Institute ORCID

Also Known As

Andrew O. Giacomelli, F Piccioni, F. Piccioni, Federica Piccioni, Frederica Piccioni, Piccioni, F., Piccioni, Federica

357

Publications

11.9K

Citations

H-Index

100

Concepts

All Affiliations

Broad Institute Dana-Farber Cancer Institute Harvard University Massachusetts General Hospital Brigham and Women's Hospital

About

Federica Piccioni is an author at Broad Institute specializing in medicine, cell biology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	3.9K
2	Natural Sciences	5	5	224
3	Engineering	4	4	3.8K
4	Health Sciences	2	2	583
5	Social Sciences	1	1	123

Federica Piccioni

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles Aravind Subramanian, Rajiv Narayan, Steven M. Corsello, Cell Network ScienceEngineeringData ScienceEdge ComputingComputer Engineering	2017	3.5K
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities Kendall R Sanson, Ruth E. Hanna, Mudra Hegde, Nature Communications	2018	1K
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival Diane D. Shao, Wen Xue, Elsa Krall, Cell Tumor BiologyMedicineTumor SuppressorTumor SurvivalRadiation Oncology	2014	744
Mutational processes shape the landscape of TP53 mutations in human cancer Andrew O. Giacomelli, Xiaoping Yang, Robert Lintner, Nature Genetics Genome InstabilitySomatic VariantTumor HeterogeneityMutational ProcessesCancer Genomics	2018	566
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition Cory M. Johannessen, Laura A. Johnson, Federica Piccioni, Nature	2013	450
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignancies Steffen Boettcher, Peter G. Miller, Rohan Sharma, Science	2019	416
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia Birgit Knoechel, Justine E. Roderick, Kaylyn E. Williamson, Nature Genetics Hematological MalignancyChromatinMixed-phenotype Acute LeukemiaEpigenetic ChangeMalignant Blood Disorder	2014	376
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies Romain Guièze, Vivian M. Liu, Daniel Rosebrock, Cancer Cell Lymphoid NeoplasiaMitochondrial FunctionMedicineMalignant Blood DisorderImmunology	2019	348
High-throughput Phenotyping of Lung Cancer Somatic Mutations Alice H. Berger, Angela N. Brooks, Xiaoyun Wu, Cancer Cell Somatic VariantTumor HeterogeneityMedicineGeneticsHigh-throughput Phenotyping	2016	216
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer Pingping Mao, Ofir Cohen, Kailey J. Kowalski, Clinical Cancer Research	2020	178

Page 1